Medicines & supplements – Current GIS Alerts 2026
Found 774 alerts in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Concor 5
Exceedance of the quality specification limit for N-Nitroso-Bisoprolol impurity content in Concor 5 (bisoprolol fumarate), 5 mg tablets. Potential effects: possible increased risk of adverse reactions and harm to health with long-term use of the medicine.
Concor Cor 5
The non-conformity consists in exceeding the quality specification limit for the N-nitroso-bisoprolol (NBP) impurity content in Concor Cor 5 tablets; the NBP level increases during storage within the shelf-life. Potential effects: prolonged exposure to nitrosamine contamination, possible increased carcinogenic risk.
Concor Cor 5
An out-of-specification result was found for the content of the impurity N-Nitroso-bisoprolol (NBP), which increases over the product's shelf-life in batches manufactured with a specific excipient. Potencjalne skutki: increased risk of adverse effects and cancers with long-term use.
Libtayo
A quality defect was identified: incomplete crimping, which may lead to leakage and contamination of the product, potential transmission of an infectious agent, or underdosing during patient treatment. Potential effects: infection, lack of anticancer efficacy, treatment complications.
Bromiduo
Testing by the National Medicines Institute showed non-compliance with quality requirements for the Dose mass parameter (exceeding the upper specification limit), which may result in administration of an incorrect dose of the medicine during nebulisation. Potential effects: lack of treatment efficacy or increased adverse reactions related to overdose.
Atrodil Combo
Tests showed non-compliance with the registration dossier requirements for the Dose mass parameter, exceeding the upper limit of the quality specification, which means administration of a higher than declared drug dose. Potential effects: overdose of the medicine, increased adverse reactions, cardiac arrhythmias, tremor, complications in patients with cardiovascular disease.
Teicoplanin Pharmline
Quality testing showed in 1 of 20 solvent ampoules the presence of two particles visible to the naked eye, whereas the product should be practically free from particles visible to the naked eye. Potential effects: complications after intravenous administration, inflammatory reactions, particle embolism.
Teicoplanin Pharmline
The product does not meet quality requirements due to contamination with particles visible to the naked eye in the vial with powder, although it should be practically free from such particles. Potential effects: inflammatory reactions, vascular emboli, thrombotic complications during intravenous administration.
Bendamustine Glenmark
Out-of-specification result for the "active substance content" parameter was found - lower content of bendamustine hydrochloride, which may lead to a lack of the intended treatment efficacy. Potencjalne skutki: lack of effectiveness of anticancer therapy, worsening of the disease course.
Risperidone Teva
Testing by the National Medicines Institute showed that the product does not meet quality requirements due to an out-of-specification result for the release parameter at specified time points and temperature. Potencjalne skutki: lack of treatment efficacy, fluctuations in drug levels and poor symptom control.
Risperidone Teva
The product does not meet quality requirements due to an out-of-specification result for the release parameter at specified time points and temperature. Potential effects: lack of treatment efficacy or unpredictable medicinal effect.
Risperidone Teva
The product does not meet quality requirements due to an out-of-specification result for the release parameter at specific time points and temperatures, and irregularities in particle size analysis. Potencjalne skutki: reduced treatment efficacy or unpredictable adverse reactions.
Verdin Fix composition of 6 herbs
Testing showed the presence of Salmonella bacteria in two batches of the dietary supplement in sachets for preparing an infusion. Potential effects: foodborne infection, diarrhoea, vomiting, fever.
Loperamid APTEO MED
Failure to meet quality requirements consists in exceeding the lower limit of the specification for the "active substance content" parameter, leading to reduced content and a real risk to patients' health due to lack of the intended effectiveness of the medicinal product. Potential effects: lack of treatment efficacy, risk of persistent symptoms.
Docetaxel Accord
Long-term stability studies showed out-of-specification results for related substances - the level of impurity B exceeds the registered quality specification limit. Potential effects: unknown toxicological effects and possible adverse reactions.
Verdin Fix herbal tea blend of 6 herbs
The product was found to contain Salmonella bacteria, which may lead to foodborne infection after consuming the product from this batch. Potential effects: gastrointestinal symptoms, diarrhoea, vomiting, fever.
Kwas traneksamowy Tillomed
Failure to meet quality requirements was found for the parameter of contamination with particles visible to the naked eye in the solution for injection. Potencjalne skutki: complications after intravenous administration, inflammatory reactions, embolisation by solid particles, lack of treatment safety.
Elenium
Reasonable suspicion of failure to meet quality requirements - out-of-specification result for the active substance chlordiazepoxide release parameter, which may indicate too low release of the drug from the tablet. Potencjalne skutki: lack of therapeutic effect, persistence or worsening of symptoms, withdrawal complications.
Apiolin
This batch was reported due to the risk of exceeding the acceptable daily intake limit for the N-nitroso sertraline impurity (AI 100 ng/day) and the temporary limit of 670 ng/day for long-term treatments. Potencjalne skutki: possible increased carcinogenic risk during long-term use of the medicine.
Levosimendan Farmak
The product does not meet quality requirements due to contamination with particles visible to the naked eye in the concentrate for solution for infusion. Potential effects: emboli and vessel damage, inflammatory reactions, circulatory complications during intravenous administration of the drug.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.